Cite
Mo1313 STUDY ON EXPANSION OF INDICATION OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FROM THE INVESTIGATION OF THE CASES WHO UNDERWENT ADDITIONAL ESOPHAGECTOMY AFTER NON-CURATIVE ESD
MLA
Satoru Motoyama, et al. “Mo1313 STUDY ON EXPANSION OF INDICATION OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FROM THE INVESTIGATION OF THE CASES WHO UNDERWENT ADDITIONAL ESOPHAGECTOMY AFTER NON-CURATIVE ESD.” Gastroenterology, vol. 158, May 2020, p. S-845. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........cbbc22cefb2a0bca44aa3506dec28247&authtype=sso&custid=ns315887.
APA
Satoru Motoyama, Kenta Watanabe, Katsunori Iijima, Tamotsu Matsuhashi, Akiyuki Wakita, Reina Ohba, Yusato Suzuki, So Takahashi, Sho Fukuda, Shigeto Koizumi, Noboru Watanabe, & Yosuke Shimodaira. (2020). Mo1313 STUDY ON EXPANSION OF INDICATION OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FROM THE INVESTIGATION OF THE CASES WHO UNDERWENT ADDITIONAL ESOPHAGECTOMY AFTER NON-CURATIVE ESD. Gastroenterology, 158, S-845.
Chicago
Satoru Motoyama, Kenta Watanabe, Katsunori Iijima, Tamotsu Matsuhashi, Akiyuki Wakita, Reina Ohba, Yusato Suzuki, et al. 2020. “Mo1313 STUDY ON EXPANSION OF INDICATION OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FROM THE INVESTIGATION OF THE CASES WHO UNDERWENT ADDITIONAL ESOPHAGECTOMY AFTER NON-CURATIVE ESD.” Gastroenterology 158 (May): S-845. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........cbbc22cefb2a0bca44aa3506dec28247&authtype=sso&custid=ns315887.